ELGX - Endologix, Inc.

NasdaqGS - NasdaqGS Real-time price. Currency in USD
Currency in USD

Valuation measures

Market cap (intra-day) 536.96M
Enterprise value 3183.44M
Trailing P/E N/A
Forward P/E 1-1.05
PEG ratio (5-yr expected) 1-0.02
Price/sales (ttm)0.26
Price/book (mrq)0.53
Enterprise value/revenue 31.29
Enterprise value/EBITDA 6-3.93

Trading information

Stock price history

Beta (3Y monthly) 0.30
52-week change 3-66.77%
S&P500 52-week change 318.16%
52-week high 38.9000
52-week low 32.0401
50-day moving average 32.8431
200-day moving average 35.0830

Share statistics

Avg vol (3-month) 3160.5k
Avg vol (10-day) 3153.74k
Shares outstanding 517.94M
Float 13.24M
% held by insiders 13.92%
% held by institutions 194.36%
Shares short (15 Nov 2019) 41.21M
Short ratio (15 Nov 2019) 46.54
Short % of float (15 Nov 2019) 410.55%
Short % of shares outstanding (15 Nov 2019) 46.72%
Shares short (prior month 15 Oct 2019) 41.41M

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 3N/A
Trailing annual dividend yield 3N/A
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 3N/A
Ex-dividend date 4N/A
Last split factor (new per old) 210/1
Last split date 36 Mar 2019

Financial highlights

Fiscal year

Fiscal year ends 31 Dec 2018
Most-recent quarter (mrq)30 Sep 2019


Profit margin -58.24%
Operating margin (ttm)-37.92%

Management effectiveness

Return on assets (ttm)-10.48%
Return on equity (ttm)-146.79%

Income statement

Revenue (ttm)142.31M
Revenue per share (ttm)9.87
Quarterly revenue growth (yoy)2.90%
Gross profit (ttm)91.92M
EBITDA -46.63M
Net income avi to common (ttm)-82.88M
Diluted EPS (ttm)-5.7470
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)46.59M
Total cash per share (mrq)2.61
Total debt (mrq)190.33M
Total debt/equity (mrq)272.74
Current ratio (mrq)2.22
Book value per share (mrq)3.90

Cash flow statement

Operating cash flow (ttm)-34.02M
Levered free cash flow (ttm)-20.55M